Clinical Trial Update: 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress [Phase 3]

View source ↗

Summary

A Phase 3 safety trial evaluating flibanserin (Addyi) in depressed women taking an SSRI or SNRI with decreased sexual desire and distress was terminated; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Interest Arousal Disorder
• Major Depressive Disorder

Drugs mentioned

• ADDYI (flibanserin)

Snippet

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological, Depression | Phase 3 | Status: TERMINATED | Results posted: 2016-08-24